Clinical Trial Update: Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TP-102 bacteriophage therapy in diabetic foot infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Infection

Drugs mentioned

• TP-102 bacteriophage therapy (bacteriophage TP-102)

Snippet

Sponsor: Technophage, SA | Conditions: Diabetic Foot Infection | Phase 2 | Status: COMPLETED